ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

American College of Cardiology

Forme & Santé

Éducation

Fréquence : 1 épisode/7j. Total Éps: 100

The American College of Cardiology offers select interviews and summaries of cardiology's most interesting research areas from ACCEL's renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.

Lire plusRéduire

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇨🇦 Canada - medicine
20/07/2026
#67
🇨🇦 Canada - medicine
04/07/2026
#100
🇨🇦 Canada - medicine
25/02/2026
#70
🇬🇧 Grande Bretagne - medicine
11/02/2026
#100
🇬🇧 Grande Bretagne - medicine
02/12/2025
#86
🇫🇷 France - medicine
29/09/2025
#99
🇫🇷 France - medicine
28/09/2025
#80
🇫🇷 France - medicine
27/09/2025
#53
🇨🇦 Canada - medicine
11/05/2025
#79
🇨🇦 Canada - medicine
27/01/2025
#79

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

http://www.acc.org/education-and-meetings/products-and-resources/accel-audio
69 partages
https://play.google.com/music/listen#/ps/I6dtkumvaipematzgzmbph2koiq
22 partages
https://www.nejm.org/doi/full/10.1056/NEJMoa2312572
2 partages

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 42%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

Key Messages from the ACC Board of Trustees Health Equity Action Plan

mardi 19 novembre 2024 • Durée 11:12

Disparities in health care disproportionally impact under-resourced and minority communities resulting in excess mortality and morbidity. Decreasing and eliminating these disparities will improve health statistics for all. The American College of Cardiology's (ACC) Health Equity Task Force is demonstrating its commitment to health equity through championing the improvement of patients' lived experiences, population health, and clinician well-being while reducing health care costs—the Quadruple Aim of Health Equity.

In this interview, Drs. Richard Chazal and Paul Douglass discuss Achieving Equitable Cardiovascular Care for All: ACC Board of Trustees Health Equity Task Force Action Plan. 

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

How Has Antithrombotic Therapy for PAD Changed Over the Last Decade?

mardi 12 novembre 2024 • Durée 10:37

Medical therapy is critical in preventing the worst complications of peripheral artery disease (PAD), among them heart attack, stroke, bleeding risk, and leg disease, which could lead to acute limb ischemia and amputation. Blood thinning medications (antithrombotic therapy) have shown rapid evolution and broad benefits and novel approved strategies that improve outcomes are available. It is imperative that clinicians select appropriate patients for use and consider the complex situations for management.

In this interview, Drs. Cindy Grines and Marc Bonaca discuss Antithrombotic Strategies for Patients with Peripheral Artery Disease: JACC Scientific Statement.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

What Aspects of Cardiovascular Care are Most Primed for Disruption with AI?

mardi 5 novembre 2024 • Durée 14:13

Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of advanced conditions from simple diagnostic testing, broadening the scope of early diagnosis and treatment.

What are the safe cards for the deployment of AI in real-world clinical care? In this interview, Drs. DJ Lakkireddy and Rohan Khera discuss Transforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice: JACC State-of-the-Art Review.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

Real-time AI to Influence Clinical Decisions and Practice Towards Evidence-based Care: RAPIDxAI Trial

mardi 29 octobre 2024 • Durée 10:39

Can algorithms improve the management of patients with myocardial injury? Is there a tool to aid diagnosing patients faster and more accurately leading to appropriate treatment sooner to optimize results? This study highlights the challenges and opportunities associated with the integration of artificial intelligence (AI) into health care to improve outcomes.

In this interview, Drs. Allen Taylor and Derek Chew discuss the findings of the RAPIDxAI trial: re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting evidence to practice using AI.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials

mardi 22 octobre 2024 • Durée 12:09

The BedMed and BedMed-Frail trials assisted in providing clarity as to the daily timing of prescribed blood pressure medication. The two trials, one conducted in a general primary-care population and the other among nursing-home residents, determined no difference in major cardiovascular events or safety between blood pressure (BP) medication distribution in the evening or morning.

In this interview, Drs. Anthony DeMaria and Scott Garrison review the BedMed and BedMed-Frail trials findings which proved the emphasis to patients is taking BP medication when they are least likely to forget, irrelevant of time of day.

References:

Pigazzani F, Dyar KA, Morant SV, et al. Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study. EClinicalMedicine 2024;72:102633.

Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet 2022;400:1417-25.

Hermida RC, Crespo JJ, Dominguez-Sardina M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J 2020;41:4565-76.

Hermida RC, Ayala DE, Fernandez JR, et al. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int 2013;30:280-314.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Effect of Antihypertensive Timing on Mortality and Morbidity: BedMed and BedMed-Frail Trials

mardi 22 octobre 2024 • Durée 12:09

References:

Pigazzani F, Dyar KA, Morant SV, et al. Effect of timed dosing of usual antihypertensives according to patient chronotype on cardiovascular outcomes: the Chronotype sub-study cohort of the Treatment in Morning versus Evening (TIME) study. EClinicalMedicine 2024;72:102633.

Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet 2022;400:1417-25.

Hermida RC, Crespo JJ, Dominguez-Sardina M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur Heart J 2020;41:4565-76.

Hermida RC, Ayala DE, Fernandez JR, et al. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int 2013;30:280-314.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K Trial

mardi 15 octobre 2024 • Durée 09:23

The goal of the TIGHT K trial was to evaluate if prescribing relaxed control of potassium levels and only giving supplements in the rare event that levels became pathologically low was equally as effective in preventing atrial fibrillation (AFib) after cardiac surgery as tightly controlling levels.

In this interview, Drs. Steven Nissen and Benjamin O'Brien discuss the TIGHT K trial results which proved that practitioners can safely cease the widespread practice of maintaining high-normal potassium levels after isolated coronary artery bypass grafting surgery. Additional benefits include improved tpatient experience and reduced patient cost.

References:

O'Brien B, Campbell NG, Allen E, et al; TIGHT K Investigators. Potassium supplementation and prevention of atrial fibrillation after cardiac surgery: the TIGHT K randomized clinical trial. JAMA 2024;332:979-88.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

Older Patients With NSTEMI Randomized Interventional Treatment: SENIOR-RITA Trial

mardi 8 octobre 2024 • Durée 06:52

The goal of the SENIOR RITA trial was to evaluate routine invasive therapy compared with conservative therapy among older patients with non–ST-elevation myocardial infarction. Additionally, the trial assessed whether optimal medical therapy or coronary angiography and stents are beneficial in older adults with heart attacks.

In this interview, Drs. Nanette Kass Wenger and Vijay Kunadian discuss the SENIOR RITA trial results and the importance of individualizing routine invasive therapy in individuals ≥75 years of age.

References:

Kunadian V, Mossop H, Shields C, et al., for the British Heart Foundation SENIOR-RITA Trial Team and Investigators. Invasive Treatment Strategy for Older Patients With Myocardial Infarction. N Engl J Med 2024;Sep 1:[Epub ahead of print].

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

Fasting or No Fasting Before Cardiac Catheterization Procedures: SCOFF Trial

mardi 1 octobre 2024 • Durée 11:31

Fasting is a routine part of preparing for a heart procedure. Research found through the SCOFF trial suggests that for certain procedures, removing the need to fast is safer and more comfortable for patients.

In this interview, Drs. Roxana Mehran and David Ferreira discuss new evidence from the SCOFF trial and the possibility of reconsidering fasting requirements in clinical guideline.

References:

Ferreira D, Hardy J, Meere W, et al. Safety and care of no fasting prior to catheterization laboratory procedures: a non-inferiority randomized control trial protocol (SCOFF trial). Eur Heart J Open 2023;3:oead111.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Lire plusRéduire

Top Takeaways from 2024: EP with Dhanunjaya Lakkireddy, MD, MBA, FACC

jeudi 19 décembre 2024 • Durée 17:56

In this interview, Dhanunjaya Lakkireddy, MD, MBA, FACC, and Alison L. Bailey, MD FACC, discuss the Top Electrophysiology (EP) Takeaways from 2024. Dr. Lakkireddy discusses climate change, high school mandated education on cardiopulmonary resuscitation, important trials impacting atrial fibrillation including PROMPT-AF and ARREST-AF, and more.

Sang C, Liu Q, Lai Y, et al. Pulmonary vein isolation with optimized linear ablation vs pulmonary vein isolation alone for persistent AF: the PROMPT-AF randomized clinical trial. JAMA 2024;Nov 18:[ePub ahead of print].

Wood S. Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

(tctMD website). 2024. Available at https://www.tctmd.com/news/lifestyle-and-risk-factors-matter-af-burden-metformin-may-not-trim-af. Accessed 12/17/24.

Verma S, Butler J, Borlaug BA, et al.; on behalf of STEP-HFpEF and STEP-HFpEF DM Investigators. Atrial fibrillation and semaglutide effects in obesity-related heart failure with preserved ejection fraction: STEP-HFpEF program. J Am Coll Cardiol 2024;84:1603-14.

Sapp JL, Tang AS, Parkash R, et al., for the VANISH2 Study Team. Catheter ablation or antiarrhythmic drugs for ventricular tachycardia. N Engl J Med .

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !

À propos Méthodologie Contact Me soutenir Politique de confidentialité

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research – Détails, épisodes et analyse

Détails du podcast

Classements récents

Apple Podcasts

Spotify

Liens partagés entre épisodes et podcasts

Other36

Apple Podcast2

Qualité et score du flux RSS

Historique des publications

Derniers épisodes publiés

Podcasts et contenus similaires

Podcasts Similaires Basées sur le Contenu

Apple Podcasts

Spotify

Podcasts Similaires Basées sur le Contenu

Other36

Apple Podcast2